The Di-methyl-Histone H3.1 (K4) Recombinant Monoclonal Antibody is a highly specific research tool designed to detect lysine 4 di-methylation (H3K4me2) on histone H3.1, a post-translational modification critical for chromatin structure, gene regulation, and epigenetic memory. This antibody is engineered to target the H3K4me2 epitope, enabling precise analysis of its role in transcriptional activation, developmental regulation, and disease mechanisms.
Target: Di-methylated lysine 4 (K4) on histone H3.1
Applications: ChIP-seq, Western blot (WB), immunocytochemistry (ICC), immunofluorescence (IF), and intracellular flow cytometry
Reactivity: Human, mouse, rat, and other species (varies by product)
Type: Recombinant monoclonal antibody
The antibody is generated via recombinant DNA technology, which ensures high specificity and reproducibility. The process involves:
Cloning: Genes encoding the antibody’s heavy and light chains are cloned from immunized organisms or synthetic libraries.
Expression: Host cells (e.g., mammalian or bacterial systems) produce the antibody, which is then purified using affinity chromatography.
Validation: Rigorous testing in applications like ChIP-seq, WB, and ICC confirms target binding and minimal cross-reactivity .
The antibody is optimized for diverse experimental workflows:
Application | Dilution Range | Source |
---|---|---|
Western Blot (WB) | 1:500–1:2000 | |
ICC/IF | 1:50–1:500 | |
ChIP-seq | 2–5 µg per 25–30 µg chromatin | |
Flow Cytometry | 1:150–1:500 |
ChIP-seq: Effective for mapping H3K4me2-enriched regions in promoters and enhancers .
ICC/IF: Reveals nuclear localization patterns, with heterogeneity observed in single cells due to dynamic chromatin states .
WB: Detects a band at ~15–17 kDa, consistent with histone H3.1 size .
Specificity: Minimal cross-reactivity to other histone modifications (e.g., H3K9me3) .
Consistency: Recombinant production reduces lot-to-lot variability .
Sensitivity: Detects low-abundance H3K4me2 marks in complex samples .
H3K4me2 is linked to transcriptional activation and chromatin accessibility. Studies using ab32356 have shown:
ChIP-seq Data: Enrichment at promoters of actively transcribed genes in HeLa cells .
Disease Implications: Altered H3K4me2 patterns in cancer (e.g., cervical carcinoma) correlate with gene dysregulation .
IF studies reveal heterogeneity in H3K4me2 staining across cells, reflecting context-dependent chromatin states .
CUT&RUN: Demonstrated high-resolution mapping of H3K4me2 in HeLa cells .
Flow Cytometry: Quantifies intracellular H3K4me2 levels, useful for studying epigenetic drug responses .
The production of the di-methyl-Histone H3.1 (K4) recombinant monoclonal antibody is a meticulously crafted process. It begins with the cloning of genes encoding the HIST1H3A antibody, encompassing both heavy and light chains. These cloned genes are then integrated into expression vectors, which are subsequently introduced into host cells through transfection. The host cells are then tasked with producing and secreting the antibody. To ensure its purity and efficacy, the antibody undergoes a rigorous purification process utilizing affinity chromatography. After purification, the antibody is subjected to comprehensive functionality testing across a range of applications, including ELISA, WB, ICC, and IF, making it a versatile tool for accurately detecting the human and mouse HIST1H3A proteins di-methylated at K4.
Di-methylation of Histone H3.1 at lysine 4 (K4) plays a pivotal role in various cellular processes, including transcriptional activation, chromatin accessibility, developmental regulation, epigenetic memory, coordinated gene regulation, and has implications in diverse disease states.
Histone H3.1 is a core component of nucleosomes. Nucleosomes serve to wrap and compact DNA into chromatin, thereby limiting DNA accessibility to cellular machineries that rely on DNA as a template. Consequently, histones play a central role in the regulation of transcription, DNA repair, DNA replication, and chromosomal stability. DNA accessibility is regulated by a complex set of post-translational modifications of histones, often referred to as the histone code, alongside nucleosome remodeling.